United Kingdom· GB-APID-44977111000001108
Nustendi 180mg/10mg tablets
A bempedoic acid and ezetimibe product containing bempedoic acid + ezetimibe, registered in United Kingdom by Pilsco Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bempedoic acid and ezetimibe is registered in 10 of 19 countries.
Countries holding a registration under ATC C10BA10 (bempedoic acid and ezetimibe), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Bempedoic acid and ezetimibe · ATC C10BA10
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bempedoic acid + Ezetimibe
- Manufacturer
- Pilsco Ltd
- Country
- United Kingdom (GB)
- ATC code
- C10BA10
- ATC class
- Bempedoic acid and ezetimibe
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bempedoic acid and ezetimibe in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNUSTENDIDaiichi Sankyo Europe GmbH, Mnichov
- SwitzerlandNustendi 180 mg / 10 mg, FilmtablettenDaiichi Sankyo (Schweiz) AG
- United StatesNexlizetEsperion Therapeutics, Inc.
- SwedenNustendi 180 mg/10 mg Filmdragerad tablettDaiichi Sankyo Europe GmbH
- IcelandNustendiDAIICHI SANKYO EUROPE GmbH*
- NetherlandsNustendi 180 mg/10 mg filmomhulde tablettenDAIICHI SANKYO EUROPE GmbH
- PolandNustendiDaiichi Sankyo Europe GmbH
- SpainNUSTENDI 180 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULADaiichi Sankyo Europe Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nustendi
- Liechtenstein · Nustendi
- Norway · Nustendi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08f3eedd-8d8a-4638-8fca-7aa2b150b68d GET /v1/drugs/08f3eedd-8d8a-4638-8fca-7aa2b150b68d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44977111000001108",
"desc": "Nustendi 180mg/10mg tablets (Pilsco Ltd)",
"form": "Oral tablet",
"vpid": "38931411000001105",
"source": "dmd",
"vtm_id": "870616001",
"strength": "10 mg",
"substance": "Bempedoic acid + Ezetimibe",
"ingredient": "Ezetimibe",
"supplier_code": "37621811000001104"
}See everything about bempedoic acid and ezetimibe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.